Cesare Gridelli

Azienda Ospedaliera S.Giuseppe Moscati — Italy

Medicine · Health Sciences

67h-index19.3kcitations549works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(398), Lung Cancer Research Studies(250), Lung Cancer Diagnosis and Treatment(165), Colorectal Cancer Treatments and Studies(92), Cancer therapeutics and mechanisms(61)

Publications546 total

EP.11.03 First Line Chemo-Immunotherapy Prognostic Factors Predicting Non Small Cell Lung Cancer Overall Survival
Journal of Thoracic Oncology·2025
Neoadjuvant therapy of NSCLC: a review of the use and impact of monoclonal antibodies
Expert Opinion on Biological Therapy·2025
The Italian Mauris Phase IIIb Trial of Atezolizumab Plus Carboplatin and Etoposide for Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer: 3-Year End-of-Study Results
Clinical Lung Cancer·2025Open Access
The Role of Osimertinib in Stage I–II Non-Small-Cell Lung Cancer with Activating EGFR Mutation
Targets·2025· 1 citedOpen Access
44P: First-line chemo-immunotherapy prognostic factors predicting non-small cell lung cancer (NSCLC) overall survival: Multicentric observational study
Journal of Thoracic Oncology·2025Open Access
New Treatment Strategies in Advanced Epidermal Growth Factor Receptor-Driven Non-Small Cell Lung Cancer: Beyond Single Agent Osimertinib
Cancers·2025· 3 citedOpen Access
Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel Meeting
Current Oncology·2025· 4 citedOpen Access
Investigating osimertinib plus chemotherapy in EGFR-mutated advanced non-small cell lung cancer
Expert Opinion on Pharmacotherapy·2025
Debate on first-line treatment strategies in advanced non-small cell lung cancer with EGFR mutation: An expert panel meeting by the Italian Association of Thoracic Oncology (AIOT)
Lung Cancer·2025· 3 cited
Corrigendum to “Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials”
ESMO Open·2024Open Access
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy
Pathologica·2024Open Access
Novel Combination of Therapeutic Approaches in Advanced NSCLC with EGFR Activating Mutations
Targets·2024· 1 citedOpen Access
Erratum to “Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813–819]”
Journal of Thoracic Oncology·2024Open Access
Targeting ALK receptors in non-small cell lung cancer: what is the road ahead?
Expert Opinion on Therapeutic Targets·2024· 4 cited
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials
ESMO Open·2024· 10 citedOpen Access
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial
The Oncologist·2024· 12 citedOpen Access
The Role of Adjuvant Chemotherapy before Osimertinib in Epidermal Growth Factor Receptor Mutant Resected Non-Small Cell Lung Cancer and Communicating It to Patients
Current Oncology·2024· 1 citedOpen Access
Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion
Current Oncology·2023· 4 citedOpen Access
Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution
The Journal of Liquid Biopsy·2023Open Access
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial
The Lancet·2023· 86 cited
page 1 of 28Next →

Frequent Co-authors

Paolo Maione(15), Antônio Rossi(14), Massimo Di Maïo(13), Ciro Gallo(13), Francesco Perrone(12), Fortunato Ciardiello(9), Alessandro Morabito(7), Vittorio Gebbia(6), Santi Barbera(6), Enriqueta Felip(5), Paolo Chiodini(5), Alessandra Bearz(4), Lucio Crinò(4), Maria Carmela Piccirillo(4), Adolfo Favaretto(4), Luigi Manzione(4), Francesco Rosetti(4), Sergio Robbiati(4), Federica Perrone(4), Assunta Sgambato(4)